Treatment Regimens for Mifegyne and Cytotec

Phase 3

• Conditions: Medical Abortion
• Interventions: Drug: mifegyne and cytotec

• Registration Number: NCT00920465
• Lead Sponsor: Western Galilee Hospital-Nahariya

Brief Summary

The purpose of this study is to test two regimens of mifegyne and cytotec for medical abortion. The investigators hypothesize that administration of both medications during one hospital visit will not compromise effectiveness.

Detailed Description

Not available

Study Timeline

• Study Start: 2009-06
• Study First Submitted: 2009-06-12
• Study First Submitted QC: 2009-06-12
• Study First Posted: 2009-06-15
• Status Verified: 2010-11
• Last Update Submitted: 2011-05-24
• Last Update Posted: 2011-05-25
• Primary Completion: 2011-12
• Study Completion: 2011-12

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: Female
• Target Recruitment: 200

Inclusion Criteria

• above age 18,
• for whom Mifegyne and cytotec are indicated.

Exclusion Criteria

• inflammation of oral cavity.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
one-visit	mifegyne and cytotec	-
two-visit	mifegyne and cytotec	-

Primary Outcome Measures

Name	Time	Method
percentage of complete abortion	one month

Trial Locations

Locations (1)

Western Galilee Hospital- Nahariya; 🇮🇱 Nahariya, Israel